|
#861
|
|||
|
|||
|
#862
|
|||
|
|||
|
DuPont can still easily afford to properly compensate for the damage their product has done to property owners. For the full year, DuPont earned almost $2.8 billion, or $2.95 per share, on sales of $34.8 billion.
|
|
#863
|
|||
|
|||
|
DuPont doesn't just kill trees, they kill people
(See my previous link to the Dispatch article re: diseases in Ohio caused by DuPont)
CEO Ellen Kullman: "We've adjusted our plans to meet the changing market environment and grow our businesses in a slow-growth world economy." Hummmm, Yes, DuPont, you are certainly changing the environment, and you've contributed to the slow growth of plants and people, despite the economy. |
|
#864
|
|||
|
|||
|
...and sooner or later, they will either willingly or through the courts.
|
|
#865
|
|||
|
|||
|
Just in case you folks want to remind Nick, CFO Dupont, that there are still folks out there waiting for a fair resolution to their deadly weed killer.
"For the full year, DuPont earned almost $2.8 billion, or $2.95 per share, on revenue of $34.8 billion. That's down from last year's net income of almost $3.5 billion, or $3.68 per share, on revenue of $33.7 billion. Sales volumes fell 2 percent. DuPont said it expects operating earnings excluding significant items will range from $3.85 to $4.05 per share in 2013, up from $3.77 per share last year. One-time items affecting fourth-quarter results included $135 million to resolve legal claims stemming from the use of DuPont's Imprelis weedkiller, bringing the total amount spent on Imprelis claims to $750 million. DuPont chief financial officer Nick Fanandakis said the company was working to validate and resolve claims regarding damage to trees, particularly evergreens such as Norway spruce and white pine, linked to the weed killer. "We want to bring closure to this as soon as possible," he said." |
|
#866
|
|||
|
|||
|
Well many of us haven't been paid YET, so the 750 M number should be increasing shortly.
|
|
#867
|
|||
|
|||
|
For those still without an attorney, pay attention to statute of limitations since we're getting closer to 2 years since Imprelis damage began to be noticed. Of course, some are reporting new damage being noticed even after applications from 2011. Everytime a site visit has been done for me, either by Dupont rep or independents, more damage is found.
|
|
#868
|
|||
|
|||
|
It will be interesting to see how things come out this spring....
Haven't heard anything from the attorney--do you know where things are? |
|
#869
|
|||
|
|||
|
I'm patient, but also don't discuss anything in public that may be told to me privately. I'm sure you understand. You can follow any federal court documents that are made public. There are some sites you can possibly join, or go to a federal court and ask for records in person.
|
|
#870
|
|||
|
|||
|
anyone have any news????
"01/22/2013 02:05:12 PM EST Imprelis Litigation Settlement Listed For Hearing Feb. 5 In Philadelphia Courthouse Posted byLexisNexis® Mealey's™ Emerging Toxic Torts Legal News PHILADELPHIA - The multidistrict Imprelis products liability litigation in the U.S. District Court for the Eastern District of Pennsylvania is stayed; the exception to the stay is a West Virginia case that the plaintiffs aver in a Jan. 3 reply brief should be remanded for lack of diversity jurisdiction (In re: Imprelis Herbicide Marketing, Sales Practices & Products Liability Litigation, No. 11-2284, MDL 2284, E.D. Pa.; See 8/21/12, Page 34; Jim Bordas, et al. v. E.I. DuPont de Nemours & Co., et al., No. 12-6446, E.D. Pa.)." |
![]() |
| Bookmarks |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
|
|












Linear Mode
